Total Funding
29
Total FundingSeed raised
Growth Score
pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
594255
Revolutionizing the way to approach pathologies with chronic inflammations.
- Miriam Lerner: Co-CEO, CTO
Tuvia Sofinzon: CEO
About the Company
Improdia’s mission is to optimize personalized treatments for patients suffering from pathologies characterized by chronic inflammation. In the last half century the incidence and prevalence of these cases are steadily increasing, with further rises expected. Improdia is developing a kit, based on revolutionary biomarkers, that can evaluate the
individuals’ immune status and inflammatory conditions by means of a simple, rapid, reliable and non-invasive blood test. This immune status detecting golden standard kit will enable Improdia to be a world leader in this widespread medical field.
